Archives

ASCENT Pitch Competition Winner

Congratulations to our ASCENT Virtual Pitch Event winner, CEREBRO Therapeutics Inc., led by Martin Levesque! Earlier today, we had the privilege of watching our nine ASCENT companies deliver high-impact virtual…
Read more

ASCENT Cohort 1 – Pitch Competition

We’re excited to announce our upcoming Virtual Pitch Competition as part of the CBV ASCENT Program! Nine high-potential companies from our current cohort will take the virtual stage to pitch…
Read more

ASCENT: Fit For Funding

Capital BioVentures (CBV), a leading biotech accelerator, dedicated to supporting the growth of early-stage life sciences companies, is proud to announce the launch of its newest offering, the ASCENT Program...
Read more

Strategic Partnership

The Stem Cell Network (SCN) and Capital BioVentures (CBV) are pleased to announce a new partnership to accelerate the development and commercialization of regenerative medicine innovations...
Read more

Inaugural Cohort Announced

Capital BioVentures (CBV), Ottawa's Biotech Accelerator Program, proudly announces the first cohort of companies selected for its support programming. Seven innovative enterprises have been chosen...
Read more

Federal Funding Investment

An organization aimed at incubating Ottawa biotechnology startups says it’s poised to help several promising companies commercialize their products after securing a multimillion-dollar grant from the federal government...
Read more
Capital BioVentures is an Ottawa Canada founded wet-lab accelerator program that removes hurdles for our Canadian innovators, while fostering a collaborative and cohesive ecosystem.
Subscribe to Our Mailing List for Our Latest News & Announcments
© 2026 All rights reserved.
Privacy Policy

MACS Quant 10 Configuration